Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Mondobiotech Holding AG Basel (RLFTF) Message Board

$RLFTF DD (copy) by OU2 on Ya-hoo-o Email receiv

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 653
(Total Views: 504)
Posted On: 01/12/2021 7:34:49 AM
Avatar
Posted By: mc67
$RLFTF DD (copy) by OU2 on Ya-hoo-o Email received from Relief Investor Relations in response to an email I sent regarding the RS projections shared this past week.

It is clear from their response they were projecting midterm to long-term and not the immediate short-term (prior to top line results). In the direct quote below they used the term “future” as in not now. Here is the exact quote

“A reverse stock split on the Swiss stock exchange is certainly an option Relief may explore in the future or the issuance of an American depositary receipt (ADR). These steps would be taken in order to enable the Company to have a more attractive stock price per share. Relief will continue to evaluate this process in 2021 and update shareholders should more definitive plans take shape.”

So everyone needs to calm down. There are no definitive plans - meaning nothing immediate.

Furthermore, the language suggests they would not do anything now prior to RCT data reveal, and possibly not even until after EUA.

It appears that the 1/20 conversion was likely an illustration of what they can do to uplist, albeit the choice of timing and disclosing an exact ratio caused undo concern with investors.

RS is very likely but not until strength is established for the company.

There are multiple catalysts to tie a favorable RS to, such as EUA for IV formula, or Top Line for Inhaled formula, or full BLA for either.

To do it prior adds unnecessary stress on the share price, but a favorable RS with wind in our sails is an amazing opportunity that we should all support if you understand corporate finance.

Long RLFTF,

OU


(1)
(0)




Mondobiotech Holding AG Basel (RLFTF) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  


$MJ




Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us